FDA Clears New Sunscreen Ingredient for U.S. Market After Two Decades

The U.S. Food and Drug Administration has approved bemotrizinol (BEMT), marking the first new general sunscreen ingredient in 20 years. This development is welcomed by dermatologists and oncologists, as it is expected to provide enhanced and longer-lasting protection against sun damage. The approval comes amidst rising melanoma rates and follows years of regulatory delays for BEMT, which has been available in Europe for some time.